Pharma companies which embrace social media can reap many benefits beyond marketing, but they must be aware of the regulations and keep within guidelines to avoid heavy penalties.
There’s no doubt that CAR-T therapies have transformed the treatment of many blood cancers, but a risk of secondary malignancies has cast a pall over the class.